Physician profile

George J Juang

Clinical Cardiac Electrophysiology · Flushing, NY

NPI 1003802547

$197,563.35

in general payments reported to CMS, 2019-2025

38 companies · $4,412 in 2025

The $4,412 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).

See the full distribution for Clinical Cardiac Electrophysiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$40,503.50
Food and Beverage$11,838.89
Travel and Lodging$2,041.79
Education$146.10

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Janssen Pharmaceuticals, INC $168,104.57 2019-2024 Xarelto
Biotronik INC. $8,289.41 2019-2025 Acticor 7 Vr-T Dx, Amvia Edge, Biomonitor
Sanofi-Aventis U.S. LLC $7,182.21 2019-2024
Boston Scientific Corporation $2,189.79 2020-2025 Watchman Flx
Atricure, INC. $1,673.63 2024
Merck Sharp & Dohme LLC $1,247.80 2021-2025 Verquvo, Capvaxive
Astrazeneca Pharmaceuticals LP $1,092.15 2020-2025 Airsupra, Breztri, Farxiga
Kestra Medical Technology Services, INC. $1,013.96 2024-2025 Assure Wcd
Janssen Research & Development, LLC $868.11 2023
Amgen INC. $784.11 2022-2025 Repatha, Repatha
Novartis Pharmaceuticals Corporation $677.24 2019-2025
Medtronic Vascular, INC. $520.93 2019
Glaxosmithkline, LLC. $512.78 2023-2025 Trelegy Ellipta, Arexvy, Shingrix
Altathera Pharmaceuticals LLC $500.00 2020
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $427.35 2019-2024 Lifevest
Show all 38 companies
CompanyGeneral paymentsYearsTop products
Boehringer Ingelheim Pharmaceuticals, INC. $332.23 2020-2025 Jardiance
E.R. Squibb & Sons, L.L.C. $267.71 2022-2025 Camzyos, Eliquis
Shockwave Medical, INC $227.63 2022
Novo Nordisk INC $206.36 2024-2025 Ozempic, Rybelsus, Wegovy
Ethicon US, LLC $193.60 2023-2025 Vistaseal, Stratafix, Dermabond
Philips North America LLC $149.64 2024-2025 Coronary Other, (Bq9) Coronary Ivus
Medical Device Business Services, INC. $137.01 2025 Stratafix
Baxter Healthcare $114.72 2025 Hillrom - Eli280 Cardiograph
Abiomed $111.98 2024-2025 Impella
Pfizer INC. $99.44 2019-2025
Medtronic, INC. $84.79 2024-2025 Micra, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan
Abbvie INC. $81.40 2024
Avanos Medical $72.72 2019
Lexicon Pharmaceuticals, INC. $71.53 2023 Inpefa
Irhythm Technologies, INC. $61.03 2019-2024 Zio Monitor, Zio Xt Patch
Csl Behring $55.39 2023 Kcentra
Edwards Lifesciences Corporation $49.30 2022
Chiesi USA, INC. $35.93 2024-2025 Kengreal
Alnylam Pharmaceuticals INC. $34.41 2020
Astellas Pharma US INC $28.47 2020-2021
Abbott Laboratories $24.12 2024 Xience Skypoint
Actelion Pharmaceuticals US, INC. $23.70 2022
Terumo Medical Corporation $16.20 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

George J Juang

$197,563.35

in general payments reported 2019-2025

Years
2019-2025
Top company
Janssen Pharmaceuticals, INC
Context
The $4,412 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).

https://glasscript.com/doctor/45289/george-j-juang

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.